Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder

NCT01504659 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Administrative issues

Conditions

Bipolar Disorder

Interventions

DRUG: Ketamine hydrochloride injection
DRUG: Flat tonic water (e.g., Canada Dry Tonic Water)

Sponsor

Juvenile Bipolar Research Foundation